As immunisation emerges as the world’s primary weapon to combat COVID-19, much more work is needed to improve electricity access so vaccines can be refrigerated.
Sheena G. Sullivan, WHO Collaborating Centre for Reference and Research on Influenza y Kanta Subbarao, The Peter Doherty Institute for Infection and Immunity
Decades of experience with influenza offers insights into how we should handle new SARS-CoV-2 variants, and the threat they pose to vaccine effectiveness.
A vaccination queue-jumping scandal in Peru has caused a massive uproar in the South American country. It could also be a wake-up call for all nations.
So far, most vaccines in the US are mRNA vaccines. These represent a new technology and are likely to take over the vaccine world. But how do they work? What are their weaknesses? Five experts explain.
Veldon Coburn, L’Université d’Ottawa/University of Ottawa
The media reporting on Indigenous vaccine hesitancy is as sensational as it is incorrect. Indigenous people, for the most part, are not more vaccine hesitant than non-Indigenous Canadians.
There is a difference between people who deliberately seek out vaccines outside the system, and those who are offered them because they’re about to expire.
The coronavirus pandemic has driven a lot of scientific progress in the past year. But just as some of the social changes are likely here to stay, so are some medical innovations.
Religious opposition over a link to abortions performed decades ago and misunderstandings about effectiveness could lead to a nightmare of angry patients and wasted vaccine.
A year after it became clear that COVID-19 was becoming a pandemic, there is still no cure, but doctors have several innovative treatments. Some are keeping patients out of the hospital entirely.
We analysed the public communication strategies that Australia and France used to promote childhood immunisation. There are lessons to be learned for the government’s current COVID vaccine campaign.
Dean Faculty of Health Sciences and Professor of Vaccinology at University of the Witwatersrand; and Director of the SAMRC Vaccines and Infectious Diseases Analytics Research Unit, University of the Witwatersrand